NO975560L - Fremgangsmåte for å redusere bentap - Google Patents

Fremgangsmåte for å redusere bentap

Info

Publication number: NO975560L
Authority: NO; Norway
Prior art keywords: bone loss; pyrrolidinyl; alkyl; compound; formula
Prior art date: 1995-06-06

Application number

NO975560A

Other languages

English (en)

Norwegian (no)

Other versions

NO975560D0 (no

Inventor

George Joseph Cullinan

Steven A Fontana

Robin S L Fuchs-Young

Andrew Lawrence Glasebrook

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-06-06

Filing date

1997-12-02

Publication date

1998-01-26

1997-12-02 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

1997-12-02 Publication of NO975560D0 publication Critical patent/NO975560D0/no

1998-01-26 Publication of NO975560L publication Critical patent/NO975560L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Engineering & Computer Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)

NO975560A 1995-06-06 1997-12-02 Fremgangsmåte for å redusere bentap NO975560L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US47111195A	1995-06-06	1995-06-06
PCT/US1996/008810 WO1996039141A1 (en)	1995-06-06	1996-06-05	Methods for minimizing bone loss

Publications (2)

Publication Number	Publication Date
NO975560D0 NO975560D0 (no)	1997-12-02
NO975560L true NO975560L (no)	1998-01-26

Family

ID=23870302

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO975560A NO975560L (no)	1995-06-06	1997-12-02	Fremgangsmåte for å redusere bentap

Country Status (27)

Country	Link
EP (1)	EP0747056B1 (pt)
JP (1)	JP2001501907A (pt)
KR (1)	KR19990022497A (pt)
CN (1)	CN1239429A (pt)
AR (2)	AR003134A1 (pt)
AT (1)	ATE187643T1 (pt)
AU (1)	AU696927B2 (pt)
BR (1)	BR9608390A (pt)
CA (1)	CA2223174A1 (pt)
CO (1)	CO4700447A1 (pt)
CZ (1)	CZ383097A3 (pt)
DE (1)	DE69605600T2 (pt)
DK (1)	DK0747056T3 (pt)
EA (1)	EA199800014A1 (pt)
ES (1)	ES2142545T3 (pt)
GR (1)	GR3032863T3 (pt)
HU (1)	HUP9900854A3 (pt)
IL (1)	IL118573A (pt)
NO (1)	NO975560L (pt)
PE (1)	PE2298A1 (pt)
PL (1)	PL323941A1 (pt)
PT (1)	PT747056E (pt)
SI (1)	SI0747056T1 (pt)
TR (1)	TR199701508T1 (pt)
WO (1)	WO1996039141A1 (pt)
YU (1)	YU34296A (pt)
ZA (1)	ZA964681B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2001509010A (ja) *	1996-11-22	2001-07-10	アクゾ・ノベル・エヌ・ベー	Ｂｍｐ―４プロモーターならびに骨粗鬆症の予防および／または治療用の治療剤のスクリーニングにおけるその用途
GB2324726A (en) *	1997-05-01	1998-11-04	Merck & Co Inc	Combination Therapy for the Treatment of Osteoporosis
US6096764A (en) *	1997-08-21	2000-08-01	Eli Lilly And Company	Methods for inhibiting detrimental side-effects due to GnRH of GnRH agonist administration
US7005428B1 (en)	1998-06-11	2006-02-28	Endorecherche, Inc.	Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4895715A (en) *	1988-04-14	1990-01-23	Schering Corporation	Method of treating gynecomastia
US5393785A (en) *	1988-10-31	1995-02-28	Endorecherche, Inc.	Therapeutic antiestrogens
US5482949A (en) *	1993-03-19	1996-01-09	Eli Lilly And Company	Sulfonate derivatives of 3-aroylbenzo[b]thiophenes
DE4329344A1 (de) *	1993-08-27	1995-03-02	Schering Ag	Progesteronantagonistisch- und antiöstrogen wirksame Verbindungen für die Behandlung des Leiomyomata uteri

1996
- 1996-05-30 PT PT96303874T patent/PT747056E/pt unknown
- 1996-05-30 EP EP96303874A patent/EP0747056B1/en not_active Expired - Lifetime
- 1996-05-30 ES ES96303874T patent/ES2142545T3/es not_active Expired - Lifetime
- 1996-05-30 DE DE69605600T patent/DE69605600T2/de not_active Expired - Fee Related
- 1996-05-30 SI SI9630163T patent/SI0747056T1/xx unknown
- 1996-05-30 DK DK96303874T patent/DK0747056T3/da active
- 1996-05-30 AT AT96303874T patent/ATE187643T1/de not_active IP Right Cessation
- 1996-06-05 AU AU59816/96A patent/AU696927B2/en not_active Ceased
- 1996-06-05 PL PL96323941A patent/PL323941A1/xx unknown
- 1996-06-05 HU HU9900854A patent/HUP9900854A3/hu unknown
- 1996-06-05 AR ARP960102930A patent/AR003134A1/es not_active Application Discontinuation
- 1996-06-05 CN CN96195984A patent/CN1239429A/zh active Pending
- 1996-06-05 KR KR1019970708978A patent/KR19990022497A/ko not_active Application Discontinuation
- 1996-06-05 JP JP09501298A patent/JP2001501907A/ja active Pending
- 1996-06-05 BR BR9608390A patent/BR9608390A/pt not_active Application Discontinuation
- 1996-06-05 PE PE1996000409A patent/PE2298A1/es not_active Application Discontinuation
- 1996-06-05 CZ CZ973830A patent/CZ383097A3/cs unknown
- 1996-06-05 CO CO96029179A patent/CO4700447A1/es unknown
- 1996-06-05 TR TR97/01508T patent/TR199701508T1/xx unknown
- 1996-06-05 YU YU34296A patent/YU34296A/sr unknown
- 1996-06-05 ZA ZA9604681A patent/ZA964681B/xx unknown
- 1996-06-05 IL IL11857396A patent/IL118573A/xx not_active IP Right Cessation
- 1996-06-05 WO PCT/US1996/008810 patent/WO1996039141A1/en not_active Application Discontinuation
- 1996-06-05 AR ARP960102931A patent/AR003002A1/es not_active Application Discontinuation
- 1996-06-05 EA EA199800014A patent/EA199800014A1/ru unknown
- 1996-06-05 CA CA002223174A patent/CA2223174A1/en not_active Abandoned
1997
- 1997-12-02 NO NO975560A patent/NO975560L/no unknown
2000
- 2000-03-03 GR GR20000400555T patent/GR3032863T3/el unknown

Also Published As

Publication number	Publication date
CO4700447A1 (es)	1998-12-29
KR19990022497A (ko)	1999-03-25
NO975560D0 (no)	1997-12-02
PT747056E (pt)	2000-05-31
AU696927B2 (en)	1998-09-24
YU34296A (en)	1999-11-22
CN1239429A (zh)	1999-12-22
AR003134A1 (es)	1998-07-08
WO1996039141A1 (en)	1996-12-12
ATE187643T1 (de)	2000-01-15
ES2142545T3 (es)	2000-04-16
BR9608390A (pt)	1999-05-04
PL323941A1 (en)	1998-04-27
EP0747056A2 (en)	1996-12-11
CZ383097A3 (cs)	1998-09-16
IL118573A (en)	2000-01-31
EA199800014A1 (ru)	1998-06-25
DE69605600T2 (de)	2000-05-31
EP0747056B1 (en)	1999-12-15
DE69605600D1 (de)	2000-01-20
GR3032863T3 (en)	2000-07-31
AR003002A1 (es)	1998-05-27
TR199701508T1 (xx)	1998-03-21
CA2223174A1 (en)	1996-12-12
JP2001501907A (ja)	2001-02-13
PE2298A1 (es)	1998-02-28
SI0747056T1 (en)	2000-06-30
HUP9900854A3 (en)	2000-03-28
ZA964681B (en)	1997-12-05
AU5981696A (en)	1996-12-24
EP0747056A3 (en)	1997-03-05
DK0747056T3 (da)	2000-05-01
IL118573A0 (en)	1996-10-16
HUP9900854A2 (hu)	1999-08-30

Similar Documents

Publication	Publication Date	Title
US5773472A (en)	1998-06-30	Method and means for prevention of cataract
NO20063382L (no)	2006-09-20	Nye kinolinderivater
NO975581L (no)	1997-12-03	Fremgangsmåte for å redusere bentap
PT703228E (pt)	2002-07-31	Compostos de naftilo intermediarios processos composicoes que os envolvem
AR002964A1 (es)	1998-05-27	Compuestos de 1(4-hidroxifenil)-2-fenoxi-naftilo, procedimiento para prepararlos, composiciones farmaceuticas que los contienen y compuestosintermediarios de aplicacion en dicho procedimiento.
PT958296E (pt)	2003-11-28	Compostos heterociclicos processo para a sua preparacao composicoes farmaceuticas contendo-os e sua utilizacao no tratamento da diabetes e doencas relacionadas
KR950700265A (ko)	1995-01-16	고지혈증 치료에 유용한 벤조티아제핀 화합물(hypolipidaemic ben zothiazepine compounds)
NO950774L (no)	1995-09-04	Fremgangsmåte for inhibering av bentap og nedsettelse av serumkolesterol
AR003930A1 (es)	1998-09-30	Procedimiento para preparar compuestos de 2-fenil-3-fenoxi o feniltio-benzotiofeno y sales farmaceuticamente aceptables, compuestos intermediarios de aplicación exclusiva en dicho procedimiento y metodo para preparar los compuestos intermediarios mencionados
KR960701033A (ko)	1996-02-24	효능있는 칼슘 길항 및 산화방지 활성을 모두 갖는 화합물, 및 세포보호제로서 그것의 사용방법(compounds having both potent calcium antagonist and antioxidant activity and use there of as cytoprotective agents)
YU2300A (sh)	2002-10-18	Derivati supstituisanog 1,2,3,4-tetrahidronaftalina
RU94045149A (ru)	1996-10-20	Средство ингибирования легочных гипертонических заболеваний
ES2141957T3 (es)	2000-04-01	Uso de raloxifeno y sus analogos para la produccion de un medicamento para el tratamiento de enfermedades virales.
KR950032267A (ko)	1995-12-20	11,21-비스페닐-19-노르프레그난 유도체
DE69628246D1 (de)	2003-06-26	Naphthyl- und Dihydronaphthylverbindungen als Arzneimittel
NO20002099L (no)	2000-06-29	6,11-bro-erytromycinderivater
BR9812239A (pt)	2000-07-18	Composto, formulação farmacêutica, uso do composto, processos para o tratamento de distúrbios, para o tratamento de distúrbios mediados por 5-hidroxitriptamina, e, para a preparação do composto
MY106401A (en)	1995-05-30	N-imidazolyl-and-n-imidazolymethyl-derivatives of substituted bicyclic compounds.
NO944933L (no)	1995-06-22	Fremgangsmåte for å inhibere sykdomstilstander i brystet
NO975560L (no)	1998-01-26	Fremgangsmåte for å redusere bentap
NO20060277L (no)	2006-01-19	Anvendelse av bisyklo [2.2.1] heptanderivater til fremstilling av nevrobeskyttende farmasoytiske sammensetninger
NO971229D0 (no)	1997-03-17	Fremgangsmåte for minimalisering av den uterotrofiske effekt av tamoxifen og tamoxifenanaloger
AU2015259752B2 (en)	2019-06-20	Reduced central corneal thickening by use of hydrophilic ester prodrugs of beta-chlorocyclopentanes
NO994902L (no)	1999-12-07	Forebygging av brystkreft ved selektive östrogenreseptormodulatorer
ATE206431T1 (de)	2001-10-15	Antifungal fusacandine